Pilarski, R., Zielinski, H., Ciesiolka, D., and Gulewicz, K. Antioxidant activity of ethanolic and aqueous extracts of Uncaria tomentosa (Willd.) DC. J Ethnopharmacol 3-8-2006;104(1-2):18-23. View abstract.
Reinhard, K. H. Uncaria tomentosa (Willd.) D.C.: cat's claw, una de gato, or saventaro. J.Altern.Complement Med. 1999;5(2):143-151. View abstract.
Rinner, B., Li, Z. X., Haas, H., Siegl, V., Sturm, S., Stuppner, H., and Pfragner, R. Antiproliferative and pro-apoptotic effects of Uncaria tomentosa in human medullary thyroid carcinoma cells. Anticancer Res. 2009;29(11):4519-4528. View abstract.
Riva, L., Coradini, D., Di Fronzo, G., De, Feo, V, De Tommasi, N., De Simone, F., and Pizza, C. The antiproliferative effects of Uncaria tomentosa extracts and fractions on the growth of breast cancer cell line. Anticancer Res 2001;21(4A):2457-2461. View abstract.
Rodriguez H, Massey PJ, Rodriguez K, and et al. Inhibition of steroid hormone production by a nutrition supplement "una de gato," or "cat's claw". Biology of Reproduction 1998;58(suppl 1):136.
Sandoval, M., Okuhama, N. N., Zhang, X. J., Condezo, L. A., Lao, J., Angeles', F. M., Musah, R. A., Bobrowski, P., and Miller, M. J. Anti-inflammatory and antioxidant activities of cat's claw (Uncaria tomentosa and Uncaria guianensis) are independent of their alkaloid content. Phytomedicine 2002;9(4):325-337. View abstract.
Sandoval-Chacon, M., Thompson, J. H., Zhang, X. J., Liu, X., Mannick, E. E., Sadowska-Krowicka, H., Charbonnet, R. M., Clark, D. A., and Miller, M. J. Antiinflammatory actions of cat's claw: the role of NF-kappaB. Aliment.Pharmacol.Ther. 1998;12(12):1279-1289. View abstract.
Senatore, A., Cataldo, A., Iaccarino, F. P., and Elberti, M. G. [Phytochemical and biological study of Uncaria tomentosa]. Boll Soc Ital Biol Sper 1989;65(6):517-520. View abstract.
Setty, A. R. and Sigal, L. H. Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects. Semin.Arthritis Rheum 2005;34(6):773-784. View abstract.
Sheng, Y., Akesson, C., Holmgren, K., Bryngelsson, C., Giamapa, V., and Pero, R. W. An active ingredient of Cat's Claw water extracts Identification and efficacy of quinic acid. J Ethnopharmacol. 1-15-2005;96(3):577-584. View abstract.
Sheng, Y., Bryngelsson, C., and Pero, R. W. Enhanced DNA repair, immune function and reduced toxicity of C-MED-100, a novel aqueous extract from Uncaria tomentosa. J Ethnopharmacol. 2000;69(2):115-126. View abstract.
Sheng, Y., Li, L., Holmgren, K., and Pero, R. W. DNA repair enhancement of aqueous extracts of Uncaria tomentosa in a human volunteer study. Phytomedicine 2001;8(4):275-282. View abstract.
Ameye LG, Chee WS. Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence. Arthritis Res Ther 2006;8(4):R127. View abstract.
Ariani A, Parisi S, Guidelli GM, Bardelli M, Bertini A, Fusaro E. Short-term effect of topical cetylated fatty acid on early and advanced knee osteoarthritis: A multi-center study. Arch Rheumatol. 2018;33(4):438-442. View abstract.
Diehl HW, May EL. Cetyl myristoleate isolated from Swiss albino mice: an apparent protective agent against adjuvant arthritis in rats. J Pharm Sci 1994;83:296-9. View abstract.
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck D, et al. Safety of cetylated fatty acids as a novel food pursuant to regulation (EU) 2015/2283. EFSA J 2021;19(7):e06670. View abstract.
Golini J, Jones WL. Kre-Celazine® as a viable treatment for juvenile rheumatoid arthritis/juvenile idiopathic arthritis - a pilot study. J Med Food 2014;17(9):1022-6. View abstract.
Hesslink R Jr, Armstrong D 3rd, Nagendran MV, et al. Cetylated fatty acids improve knee function in patients with osteoarthritis. J Rheumatol 2002;29:1708-12. View abstract.
Hudita A, Galateanu B, Dinescu S, et al. In vitro effects of cetylated fatty acids mixture from celadrin on chondrogenesis and inflammation with impact on osteoarthritis. Cartilage. 2020;11(1):88-97. View abstract.
Kraemer WJ, Ratamess NA, Anderson JM, et al. Effect of a cetylated fatty acid topical cream on functional mobility and quality of life of patients with osteoarthritis. J Rheumatol 2004;31:767-74. View abstract.
Kraemer WJ, Ratamess NA, Maresh CM, et al. A cetylated fatty acid topical cream with menthol reduces pain and improves functional performance in individuals with arthritis. J Strength Cond Res 2005;19:475-80. View abstract.
Kraemer WJ, Ratamess NA, Maresh CM, et al. Effects of treatment with a cetylated fatty acid topical cream on static postural stability and plantar pressure distribution in patients with knee osteoarthritis. J Strength Cond Res 2005;19:115-21. View abstract.
Lee SC, Jin HS, Joo Y, Kim YC, Moon JY. The minimal effective dose of cis-9-cetylmyristoleate (CMO) in persons presenting with knee joint pain: a double-blind, randomized, placebo-controlled trial. Medicine (Baltimore). 2017 Mar;96(9):e6149.
Pampaloni E, Pera E, Maggi D, et al. Association of cetylated fatty acid treatment with physical therapy improves athletic pubalgia symptoms in professional roller hockey players. Heliyon 2020;6(7):e04526. View abstract.
Sharan D, Jacob BN, Ajeesh PS, Bookout JB, Barathur RR. The effect of cetylated fatty esters and physical therapy on myofascial pain syndrome of the neck. J Bodyw Mov Ther. 2011;15(3):363-74. View abstract.